Cholestatic Hepatic Injury Induced by Carbimazole: A Case Report and a Thorough Literature Review
<p dir="ltr">Carbimazole, a thionamide derivative, is widely used for hyperthyroidism but carries a rare risk of hepatotoxicity, including cholestatic injury. A 42‐year‐old man developed severe cholestatic jaundice 4 weeks after carbimazole initiation. Laboratory findings showed mark...
محفوظ في:
| المؤلف الرئيسي: | Bassem Al Hariri (19180066) (author) |
|---|---|
| مؤلفون آخرون: | Mohammed Omer Elbadawi Elhassan (22565375) (author), Hadil Altaj Altrify Alsidig (22565378) (author), Muad Abdi Hassan (21841835) (author), Abdalrahman Mohammed Mostafa (19180075) (author), Memon Noor Illahi (22565381) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Clinical Characteristics and Outcomes of Patients With Antithyroid Drug–Related Liver Injury
حسب: Adeel Ahmad Khan (14152953)
منشور في: (2023) -
Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
حسب: Sara Seife Hassen (14777173)
منشور في: (2020) -
Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
حسب: Anika Liu (8411805)
منشور في: (2021) -
Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats
حسب: Maisa Siddiq Abduh (16381125)
منشور في: (2023) -
Novel biomarkers for potential risk stratification of drug induced liver injury (DILI)
حسب: Mohammed Ibn-Mas’ud Danjuma (13192169)
منشور في: (2019)